Meditation as an Adjunct to the Management of Multiple Sclerosis
Background. Multiple sclerosis (MS) disease course is known to be adversely affected by several factors including stress. A proposed mechanism for decreasing stress and therefore decreasing MS morbidity and improving quality of life is meditation. This review aims to critically analyse the current l...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Neurology Research International |
| Online Access: | http://dx.doi.org/10.1155/2014/704691 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841524732745220096 |
|---|---|
| author | Adam B. Levin Emily J. Hadgkiss Tracey J. Weiland George A. Jelinek |
| author_facet | Adam B. Levin Emily J. Hadgkiss Tracey J. Weiland George A. Jelinek |
| author_sort | Adam B. Levin |
| collection | DOAJ |
| description | Background. Multiple sclerosis (MS) disease course is known to be adversely affected by several factors including stress. A proposed mechanism for decreasing stress and therefore decreasing MS morbidity and improving quality of life is meditation. This review aims to critically analyse the current literature regarding meditation and MS. Methods. Four major databases were used to search for English language papers published before March 2014 with the terms MS, multiple sclerosis, meditation, and mindfulness. Results. 12 pieces of primary literature fitting the selection criteria were selected: two were randomised controlled studies, four were cohort studies, and six were surveys. The current literature varies in quality; however common positive effects of meditation include improved quality of life (QOL) and improved coping skills. Conclusion. All studies suggest possible benefit to the use of meditation as an adjunct to the management of multiple sclerosis. Additional rigorous clinical trials are required to validate the existing findings and determine if meditation has an impact on disease course over time. |
| format | Article |
| id | doaj-art-7fd4f8a04328484fb2ec54e6628cdcb9 |
| institution | Kabale University |
| issn | 2090-1852 2090-1860 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Neurology Research International |
| spelling | doaj-art-7fd4f8a04328484fb2ec54e6628cdcb92025-02-03T05:47:30ZengWileyNeurology Research International2090-18522090-18602014-01-01201410.1155/2014/704691704691Meditation as an Adjunct to the Management of Multiple SclerosisAdam B. Levin0Emily J. Hadgkiss1Tracey J. Weiland2George A. Jelinek3Department of Medicine, The University of Melbourne, St Vincent’s Hospital, Melbourne, VIC 3065, AustraliaEmergency Practice Innovation Centre, St Vincent’s Hospital, Melbourne, VIC 3065, AustraliaDepartment of Medicine, The University of Melbourne, St Vincent’s Hospital, Melbourne, VIC 3065, AustraliaEmergency Practice Innovation Centre, St Vincent’s Hospital, Melbourne, VIC 3065, AustraliaBackground. Multiple sclerosis (MS) disease course is known to be adversely affected by several factors including stress. A proposed mechanism for decreasing stress and therefore decreasing MS morbidity and improving quality of life is meditation. This review aims to critically analyse the current literature regarding meditation and MS. Methods. Four major databases were used to search for English language papers published before March 2014 with the terms MS, multiple sclerosis, meditation, and mindfulness. Results. 12 pieces of primary literature fitting the selection criteria were selected: two were randomised controlled studies, four were cohort studies, and six were surveys. The current literature varies in quality; however common positive effects of meditation include improved quality of life (QOL) and improved coping skills. Conclusion. All studies suggest possible benefit to the use of meditation as an adjunct to the management of multiple sclerosis. Additional rigorous clinical trials are required to validate the existing findings and determine if meditation has an impact on disease course over time.http://dx.doi.org/10.1155/2014/704691 |
| spellingShingle | Adam B. Levin Emily J. Hadgkiss Tracey J. Weiland George A. Jelinek Meditation as an Adjunct to the Management of Multiple Sclerosis Neurology Research International |
| title | Meditation as an Adjunct to the Management of Multiple Sclerosis |
| title_full | Meditation as an Adjunct to the Management of Multiple Sclerosis |
| title_fullStr | Meditation as an Adjunct to the Management of Multiple Sclerosis |
| title_full_unstemmed | Meditation as an Adjunct to the Management of Multiple Sclerosis |
| title_short | Meditation as an Adjunct to the Management of Multiple Sclerosis |
| title_sort | meditation as an adjunct to the management of multiple sclerosis |
| url | http://dx.doi.org/10.1155/2014/704691 |
| work_keys_str_mv | AT adamblevin meditationasanadjuncttothemanagementofmultiplesclerosis AT emilyjhadgkiss meditationasanadjuncttothemanagementofmultiplesclerosis AT traceyjweiland meditationasanadjuncttothemanagementofmultiplesclerosis AT georgeajelinek meditationasanadjuncttothemanagementofmultiplesclerosis |